Larry Rubinstein

Publishing 1989–2020

Is this you? Claim this profile
4
Articles
425
Reads on Journament
37
Co-authors
2
Journals

This page collects the articles indexed under the name Larry Rubinstein. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 4

  1. Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.
    Terri S Armstrong, Linda Dirven, David Arons, Amanda Bates, Susan M Chang, Corneel Coens, Claire Espinasse, Mark R Gilbert, David Jenkinson, Paul Kluetz, Tito Mendoza, Larry Rubinstein and 5 more
    the lancet oncology 2020 378 reads
  2. New Guidelines to Evaluate the Response to Treatment in Solid Tumors
    Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, J. Wanders, Richard Kaplan, Larry Rubinstein, Jaap Verweij, M. van Glabbeke, Allan T. van Oosterom, Michaele C. Christian, Steve G. Gwyther
    JNCI Journal of the National Cancer Institute 2000 21 reads
  3. Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines
    Larry Rubinstein, Robert H. Shoemaker, Kenneth D. Paull, Richard Simon, S. Tosini, Philip Skehan, Dominic A. Scudiero, Anne Monks, M.R. Boyd
    JNCI Journal of the National Cancer Institute 1990 12 reads
  4. Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm
    Kenneth D. Paull, Robert H. Shoemaker, Louis Hodes, Anne Monks, Dominic A. Scudiero, Larry Rubinstein, Jacqueline Plowman, Michael R. Boyd
    JNCI Journal of the National Cancer Institute 1989 14 reads

Possible papers by Larry Rubinstein 1

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.
    as L V Rubinstein Annals of oncology : official journal of the European Society for Medical Oncology 2019
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Frequent co-authors

Publishes in